comparemela.com

Latest Breaking News On - Gary clarence shalin bhamra - Page 4 : comparemela.com

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

14.11.2023 - LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved .

United statesPeter denardoPaul mcmanus alice woodingsGary clarence shalin bhamraHoward doranJames mcculloughAtrium health wake forestAtrium healthParkland community health planClinical advisory committeeProvider network of americaAmerican diabetes associationUs patent officeDrug administrationExchange commissionCenters for medicare medicaid services

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

LONDON and SALT LAKE CITY, Oct. 06, 2023 Renalytix plc , the first company to commercialize an FDA authorized artificial intelligence enabled blood test to assess risk of progressive kidney.

United statesCity ofUnited kingdomJames mcculloughPaul mcmanus lianne applegarthPeter denardoGary clarence shalin bhamraCenters for diseaseDrug administration de novoExchange commissionInvestec bankJoslin diabetes centerUs patent officeNominated adviserJoint brokerNicholas moore

Renalytix Reports Full Year Fiscal 2023 Results

LONDON and SALT LAKE CITY, Sept. 28, 2023 Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive.

New yorkUnited statesWake forestNorth carolinaUnited kingdomCity ofRepublic of irelandGary clarence shalin bhamraPeter denardoCarefirst bluecross blueshieldChristopher millsThomas mclainHoward doranTimothy scannellCatherine costeJames mccullough

Renalytix to Report Financial Results for Fourth Quarter

LONDON and SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) Renalytix plc (NASDAQ: RNLX) (LSE: RENX) will report its fourth quarter and full year.

City ofUnited kingdomPeter denardoJames mcculloughPaul mcmanus lianne applegarthGary clarence shalin bhamraInvestec bankCall detailsNominated adviserJoint brokerNicholas mooreNick harlandNasdaq rnlxRenalytix plc

Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28

LONDON and SALT LAKE CITY, Sept. 25, 2023 Renalytix plc will report its fourth quarter and full year fiscal 2023 financial results on Thursday, September 28, 2023, before market open. The.

City ofUnited kingdomJames mcculloughPeter denardoPaul mcmanus lianne applegarthGary clarence shalin bhamraInvestec bankCall detailsNominated adviserJoint brokerNicholas mooreNick harland

vimarsana © 2020. All Rights Reserved.